Skip to content
The Nexus
DossierENTITY

Hernando Salcedo

Coverage of Hernando Salcedo in the Nexus archive.

Earliest in view: May 14 · 13:20 UTCMost recent: Jul 25 · 12:05 UTC
Co-mentioned in this coverage
pancreatic cancertopic1clinical trialtopic1RenovoRxorganization1Shaun Bagaiperson1Trans-Arterial Micro-Perfusion (TAMP)topic1Miami Cancer Instituteplace1Ripal Gandhiperson1Baptist Health Miami Cardiac & Vascular Instituteplace1
Recent coverage
  • HEALTHJul 25 · 12:05 UTCCBS NEWS
    Grandfather with pancreatic cancer beats the odds with clinical trial

    Hernando Salcedo was diagnosed with Stage III pancreatic cancer after mild symptoms. Chemotherapy worsened his condition, but he participated in a clinical trial that helped him beat the odds.

  • HEALTHMay 14 · 13:20 UTCFOX NEWS
    New cancer tech sends chemo straight to tumors

    A new cancer technology called Trans-Arterial Micro-Perfusion (TAMP) is being studied in a Phase III clinical trial for locally advanced pancreatic cancer, delivering chemotherapy directly near the tumor instead of through the entire body. This approach may reduce side effects and improve treatment outcomes. The system uses a catheter placed in an artery near the tumor to deliver chemotherapy.